Hively Brad

SEC CIK
0001891124

Latest role at each company

Trades

Every Form 4 that lists Hively Brad as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Insider trades
CompanyFiled (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
DFPHStarling Oncology, Inc.Aug 24, 20265:11 PM ETAug 21, 2026Hively BradDirectorSSaleCommon Stock−298.85K$6.5126−$1.95M411.98K−42.0%SEC10b5-1
DFPHStarling Oncology, Inc.Dec 16, 2025Dec 15, 2025Hively BradDirectorSSaleCommon Stock−13.33K$3.77−$50.27K683.72K−1.9%SEC
DFPHStarling Oncology, Inc.Aug 21, 2025Aug 19, 2025Hively BradDirectorSSaleCommon stock−20.22K$4.06−$82.1K622.98K−3.1%SEC
DFPHStarling Oncology, Inc.Jun 5, 20256:51 PM ETJun 3, 2025Hively BradDirectorSSaleCommon Stock−1.98M$2.8703−$5.67M603.5K−76.6%SEC
DFPHStarling Oncology, Inc.Apr 28, 20257:20 PM ETAmendedMar 26, 2025Hively BradDirectorPPurchaseCommon Stock+45.28K$1.0417+$47.17K712.03K+6.8%SEC
DFPHStarling Oncology, Inc.Apr 28, 20257:20 PM ETAmendedMar 26, 2025Hively BradDirectorPPurchaseCommon Stock · Derivative+22.64K$0.125+$2.83K22.64K–SEC
DFPHStarling Oncology, Inc.Dec 2, 20244:04 PM ETNov 26 – Dec 2, 2024Hively BradDirectorPPurchaseCommon stock+300K$0.1667+$50K666.75K+81.8%SEC
DFPHStarling Oncology, Inc.Nov 21, 2023Nov 17, 2023Hively BradDirectorSSaleCommon stock−25K$2.24−$56K697.07K−3.5%SEC
DFPHStarling Oncology, Inc.Nov 15, 2023Nov 13, 2023Hively BradDirectorSSaleCommon stock−47K$2.52−$118.44K724.18K−6.1%SEC
DFPHStarling Oncology, Inc.Nov 22, 2022AmendedNov 15, 2022Hively BradChief Executive OfficerSSaleCommon Stock−9.72K$2.03−$19.73K452.2K−2.1%SEC